123 related articles for article (PubMed ID: 17661061)
1. Retropharyngeal neuroblastoma in a neonate: case report and literature review.
Okazaki T; Ohshita M; Furukawa M; Ikeda K; Ozaki Y; Lane GJ; Yamataka A
Pediatr Surg Int; 2007 Oct; 23(10):1023-6. PubMed ID: 17661061
[TBL] [Abstract][Full Text] [Related]
2. Retropharyngeal neuroblastoma in an infant: management without surgery.
Matsumura R; Ohta H; Kusuki S; Yoshida H; Sato E; Hashii Y; Uehara S; Oue T; Fukuzawa M; Ishida H; Ozono K
J Pediatr Hematol Oncol; 2010 May; 32(4):e160-3. PubMed ID: 20445413
[TBL] [Abstract][Full Text] [Related]
3. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
[TBL] [Abstract][Full Text] [Related]
4. [N-myc gene copies in children with neuroblastoma and its clinical significance].
Ma XL; Gong LP; Zhou CJ; Zhang DW; Jin M; Wang HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1447-51. PubMed ID: 23257451
[TBL] [Abstract][Full Text] [Related]
5. Primary neuroblastoma: a rare cause of a retropharyngeal mass in a neonate.
Jonas NE; Thandar M; Pitcher R; Fagan JJ
J Laryngol Otol; 2006 Mar; 120(3):E15. PubMed ID: 16917993
[TBL] [Abstract][Full Text] [Related]
6. [Parapharyngeal tumor in an infant. Cervical neuroblastoma, stage IV].
Keiner S; Bootz F; Gütz U
HNO; 1999 Sep; 47(9):828-9. PubMed ID: 10525614
[No Abstract] [Full Text] [Related]
7. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.
Katzenstein HM; Bowman LC; Brodeur GM; Thorner PS; Joshi VV; Smith EI; Look AT; Rowe ST; Nash MB; Holbrook T; Alvarado C; Rao PV; Castleberry RP; Cohn SL
J Clin Oncol; 1998 Jun; 16(6):2007-17. PubMed ID: 9626197
[TBL] [Abstract][Full Text] [Related]
8. High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification.
Laprie A; Michon J; Hartmann O; Munzer C; Leclair MD; Coze C; Valteau-Couanet D; Plantaz D; Carrie C; Habrand JL; Bergeron C; Chastagner P; Défachelles AS; Delattre O; Combaret V; Bénard J; Pérel Y; Gandemer V; Rubie H;
Cancer; 2004 Sep; 101(5):1081-9. PubMed ID: 15329919
[TBL] [Abstract][Full Text] [Related]
9. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
George RE; London WB; Cohn SL; Maris JM; Kretschmar C; Diller L; Brodeur GM; Castleberry RP; Look AT
J Clin Oncol; 2005 Sep; 23(27):6466-73. PubMed ID: 16116152
[TBL] [Abstract][Full Text] [Related]
10. Neuroblastoma in children: a 10-year experience in Saudi Arabia.
al-Mulhim I
J Trop Pediatr; 1998 Apr; 44(2):77-80. PubMed ID: 9604593
[TBL] [Abstract][Full Text] [Related]
11. Congenital stage 1 neuroblastoma evolved into stage 4s.
Schiavetti A; Foco M; Ingrosso A; Chiriacò D; Ballesio L
J Pediatr Hematol Oncol; 2009 Jan; 31(1):59-60. PubMed ID: 19125091
[TBL] [Abstract][Full Text] [Related]
12. [Management strategy in neuroblastoma].
Balwierz W
Przegl Lek; 2004; 61 Suppl 2():3-8. PubMed ID: 15686038
[TBL] [Abstract][Full Text] [Related]
13. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
[TBL] [Abstract][Full Text] [Related]
14. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
[TBL] [Abstract][Full Text] [Related]
15. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M
J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726
[TBL] [Abstract][Full Text] [Related]
16. Neuroblastoma in southern Brazil: an 11-year study.
Parise IZ; Haddad BR; Cavalli LR; Pianovski MA; Maggio EM; Parise GA; Watanabe FM; Ioshii SO; Rone JD; Caleffe LG; Odone Filho V; Figueiredo BC
J Pediatr Hematol Oncol; 2006 Feb; 28(2):82-7. PubMed ID: 16462579
[TBL] [Abstract][Full Text] [Related]
17. Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study.
Perez CA; Matthay KK; Atkinson JB; Seeger RC; Shimada H; Haase GM; Stram DO; Gerbing RB; Lukens JN
J Clin Oncol; 2000 Jan; 18(1):18-26. PubMed ID: 10623689
[TBL] [Abstract][Full Text] [Related]
18. Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma.
Meitar D; Crawford SE; Rademaker AW; Cohn SL
J Clin Oncol; 1996 Feb; 14(2):405-14. PubMed ID: 8636750
[TBL] [Abstract][Full Text] [Related]
19. Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies.
van Noesel MM; Hählen K; Hakvoort-Cammel FG; Egeler RM
Cancer; 1997 Sep; 80(5):834-43. PubMed ID: 9307181
[TBL] [Abstract][Full Text] [Related]
20. Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French society of pediatric oncology.
Minard V; Hartmann O; Peyroulet MC; Michon J; Coze C; Defachelle AS; Lejars O; Perel Y; Bergeron C; Boutard P; Leverger G; Stephan JL; Thyss A; Chastagner P; Couillault G; Devalck C; Lutz P; Mechinaud F; Millot F; Plantaz D; Rialland X; Rubie H
Br J Cancer; 2000 Oct; 83(8):973-9. PubMed ID: 10993641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]